← SynDRA
PF-03758309
SynDRA canonical compound SYN0037832 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | PAK4 |
|---|
| Mechanism of action | P21 activated kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- P21 activated kinase inhibitor
- PAK4 INHIBITOR
- Serine/threonine-protein kinase PAK 4 inhibitor
Cross-references
Synonyms
- PF-3758309
- PF-309
- PK459EA5I2
- example 114 [US8530652]
- PF3758309
- compound 1 [PMID: 24432870]
- example 114 (US8530652)
- compound 1 (PMID: 24432870)
- RefChem:860475
- MFCD18633226
- US8530652, 114
- UNII-PK459EA5I2
- C25H30N8OS
- 7KC
- GTPL8937
- orb1300605
- SCHEMBL1369342
- CHEBI:93751
- EX-A849
- BDBM101536
- BDBM101618
- GLXC-90543
- YKB04415
- NSC781470
- NSC800847
- s7094
- AKOS027422746
- CCG-269617
- CS-0773
- EBC-221084
- NSC-781470
- NSC-800847
- NCGC00345784-01
- NCGC00345784-03
- NCGC00345784-05
- NCGC00345784-12
- AC-33020
- AS-56208
Look up PF-03758309 in the interactive SynDRA portal →